Bruce G. Allen Investments, LLC Halozyme Therapeutics, Inc. Transaction History
Bruce G. Allen Investments, LLC
- $126 Billion
- Q1 2025
A detailed history of Bruce G. Allen Investments, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 11 shares of HALO stock, worth $675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 9
22.22%
Holding current value
$675
Previous $430,000
63.26%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
552Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.08 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$815 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$441 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$256 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$212 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.55B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...